Insmed (INSM) Intangibles (2010 - 2026)
Insmed (INSM) recorded quarterly Intangibles of $95.6 million in Q1 2026, down 2.13% quarter-over-quarter from $97.7 million in Q4 2025.
Insmed (INSM) Intangibles (2010 - 2026) Analysis & Trends
Insmed's Intangibles history runs 17 years deep, the most recent figure standing at $95.6 million for Q1 2026.
- In Q1 2026, Intangibles changed N/A year-over-year to $95.6 million; the TTM figure through Mar 2026 stood at $95.6 million (changed N/A YoY), while the FY2025 annual figure was $97.7 million, up 66.49% from the prior year.
- Intangibles was $95.6 million for Q1 2026 at Insmed, down from $97.7 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $97.7 million in Q4 2025 to a low of $56.1 million in Q2 2025.
- Historically, Intangibles has averaged $71.2 million across 5 years, with a median of $68.1 million in 2022.
- Biggest YoY gain for Intangibles was 66.49% in 2025; the steepest drop was 8.26% in 2025.
- A 5-year view of Intangibles shows it stood at $68.8 million in 2022, then slipped by 7.35% to $63.7 million in 2023, then declined by 7.93% to $58.7 million in 2024, then surged by 66.49% to $97.7 million in 2025, then fell by 2.13% to $95.6 million in 2026.
- The last three Intangibles figures came in at $95.6 million (Q1 2026), $97.7 million (Q4 2025), and $84.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 7.73 Mn |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn | 95.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95.57 Mn |
| Dec 31, 2025 | 97.65 Mn |
| Sep 30, 2025 | 84.59 Mn |
| Jun 30, 2025 | 56.13 Mn |
| Dec 31, 2024 | 58.65 Mn |
| Jun 30, 2024 | 61.18 Mn |
| Mar 31, 2024 | 62.44 Mn |
| Dec 31, 2023 | 63.70 Mn |
| Jun 30, 2023 | 66.23 Mn |
| Mar 31, 2023 | 67.49 Mn |
| Dec 31, 2022 | 68.76 Mn |
| Sep 30, 2022 | 70.02 Mn |
| Jun 30, 2022 | 71.28 Mn |
| Mar 31, 2022 | 72.55 Mn |
| Dec 31, 2021 | 73.81 Mn |
| Sep 30, 2021 | 75.07 Mn |
| Jun 30, 2021 | 46.74 Mn |
| Mar 31, 2021 | 48.00 Mn |
| Dec 31, 2020 | 49.26 Mn |
| Sep 30, 2020 | 49.90 Mn |